Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
about
Vaccines for preventing influenza in healthy adultsInfluenzaInfluenza immunology evaluation and correlates of protection: a focus on vaccines.AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection.Vaccination in elite athletes.Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study.Evaluating the case for trivalent or quadrivalent influenza vaccines.Inactivated quadrivalent split-virus seasonal influenza vaccine (Fluarix® quadrivalent): a review of its use in the prevention of disease caused by influenza A and B.Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination.Fluarix quadrivalent vaccine for influenza.Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccines in participants >/=3 years of age: A double-blind, randomized, parallel-controlled phase III clinical trial in China[Quadrivalent influenza vaccines].Influenza vaccination in oncology patients.Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older.Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults.Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia
P2860
Q24197955-07C5B164-2B08-4137-BB94-2F536DD15829Q28066188-97447133-23AF-46BA-B8E9-56CB3B726825Q30385397-35A6F380-B23C-4B9C-8F33-E1D8DEC7A92CQ34019854-6724169A-36C6-406F-9C98-265A9409C121Q34227424-4E1A87C8-F2D7-470F-A384-99AC485BDA95Q35821862-E667104F-E744-4308-84B1-E402380C5E54Q37264968-620A193F-1546-410A-A2FF-EBE1CCEE4E20Q37375959-7594EB2C-7476-4A26-A309-F1357CA3407FQ38136067-51F20335-6E87-43BD-AB53-D704A8EED8D8Q38204774-F1D987AA-7414-4C8D-A049-258C7DF188EBQ38534169-736C67A5-2E82-4699-9B6F-9660F24D7AE7Q38660898-E78FC825-8BD2-48E0-9745-3047753CD25DQ40058830-54D7A3E0-C844-43DA-9C1D-D99D63D97F82Q41389931-3D31FC87-6AA5-48E6-B867-5A555F2008D8Q42239906-FA7BCC94-AD94-4ADA-B396-F6764FC63A98Q47613536-FECE5F8C-95DD-4205-B9FA-6740149A8978Q52579975-ADB55940-E421-4A77-932A-E0105251D16CQ57812045-11849E5D-B145-4D10-8EE4-D85EB11744B9
P2860
Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Immunogenicity and safety of q ...... ed, controlled trial in adults
@ast
Immunogenicity and safety of q ...... ed, controlled trial in adults
@en
Immunogenicity and safety of q ...... ed, controlled trial in adults
@nl
type
label
Immunogenicity and safety of q ...... ed, controlled trial in adults
@ast
Immunogenicity and safety of q ...... ed, controlled trial in adults
@en
Immunogenicity and safety of q ...... ed, controlled trial in adults
@nl
prefLabel
Immunogenicity and safety of q ...... ed, controlled trial in adults
@ast
Immunogenicity and safety of q ...... ed, controlled trial in adults
@en
Immunogenicity and safety of q ...... ed, controlled trial in adults
@nl
P2093
P2860
P356
P1476
Immunogenicity and safety of q ...... ed, controlled trial in adults
@en
P2093
Jeanne-Marie Devaster
Jiří Beran
Jolana Raupachová
Lenka Hobzová
Mathieu Peeters
Walthère Dewé
P2860
P2888
P356
10.1186/1471-2334-13-224
P577
2013-05-20T00:00:00Z
P5875
P6179
1007105114